These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 18383462)
1. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462 [TBL] [Abstract][Full Text] [Related]
2. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan. Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869 [TBL] [Abstract][Full Text] [Related]
3. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854 [TBL] [Abstract][Full Text] [Related]
4. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Zoppi MA; Ibba RM; Floris M; Monni G Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208 [TBL] [Abstract][Full Text] [Related]
5. Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model. Wright D; Syngelaki A; Staboulidou I; Cruz Jde J; Nicolaides KH Prenat Diagn; 2011 Jan; 31(1):16-21. PubMed ID: 21210476 [TBL] [Abstract][Full Text] [Related]
6. A mixture model of nuchal translucency thickness in screening for chromosomal defects: validation of a single operator dataset. Gasiorek-Wiens A; Kotsis S; Staboulidou I; Stumm M; Wegner RD; Soergel P; Schippert C; von Kaisenberg CS Prenat Diagn; 2010 Nov; 30(11):1100-6. PubMed ID: 20925129 [TBL] [Abstract][Full Text] [Related]
7. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11+0 to 13+6 weeks of gestation. Kagan KO; Valencia C; Livanos P; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2009 Jan; 33(1):18-22. PubMed ID: 19031473 [TBL] [Abstract][Full Text] [Related]
8. [Increased nuchal translucency with normal karyotype]. Nicolaides KH; Wegrzyn P Ginekol Pol; 2005 Aug; 76(8):593-601. PubMed ID: 16363364 [TBL] [Abstract][Full Text] [Related]
10. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Faiola S; Tsoi E; Huggon IC; Allan LD; Nicolaides KH Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972 [TBL] [Abstract][Full Text] [Related]
11. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture. Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228 [TBL] [Abstract][Full Text] [Related]
12. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007 [TBL] [Abstract][Full Text] [Related]
13. Fetal head-to-trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation. Falcon O; Cavoretto P; Peralta CF; Csapo B; Nicolaides KH Ultrasound Obstet Gynecol; 2005 Dec; 26(7):755-60. PubMed ID: 16163740 [TBL] [Abstract][Full Text] [Related]
15. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299 [TBL] [Abstract][Full Text] [Related]
16. Fetal trunk and head volume in chromosomally abnormal fetuses at 11+0 to 13+6 weeks of gestation. Falcon O; Peralta CF; Cavoretto P; Auer M; Nicolaides KH Ultrasound Obstet Gynecol; 2005 Oct; 26(5):517-20. PubMed ID: 16142826 [TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS; Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207 [TBL] [Abstract][Full Text] [Related]
18. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371 [TBL] [Abstract][Full Text] [Related]
19. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy. Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782 [TBL] [Abstract][Full Text] [Related]
20. First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population. Brizot ML; Carvalho MH; Liao AW; Reis NS; Armbruster-Moraes E; Zugaib M Ultrasound Obstet Gynecol; 2001 Dec; 18(6):652-5. PubMed ID: 11844209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]